Collectively, we revealed that HOXA5 may exert its anticancer effects through targeting AKR1B10, thereby leading to the inhibition of the abnormal proliferation and induction of apoptosis via activating p53 signaling in ACC cells. The gene discussed is AKR1B10; the disease is adrenal cortex carcinoma.